Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism

被引:174
作者
Villadangos, JA
Riese, RJ
Peters, C
Chapman, HA
Ploegh, HL
机构
[1] MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139
[2] BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[4] UNIV FREIBURG,INNERE MED ABT 1,FREIBURG,GERMANY
关键词
D O I
10.1084/jem.186.4.549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen-presenting cells (APC) degrade endocytosed antigens into peptides that are bound and presented to T cells by major histocompatibility complex (MHC) class II molecules. Class II molecules are delivered to endocytic compartments by the class II accessory molecule invariant chain (Ii), which itself must be eliminated to allow peptide binding. The cellular location of Ii degradation, as well as the enzymology of this event, are important in determining the sets of antigenic peptides that will bind to class II molecules. Here, we show that the cysteine protease cathepsin S acts in a concerted fashion with other cysteine and noncysteine proteases to degrade mouse Ii in a stepwise fashion. Inactivation of cysteine proteases results in incomplete degradation of Ii, but the extent to which peptide loading is blocked by such treatment varies widely among MHC class II allelic products. These observations suggest that, first, class II molecules associated with larger Ii remnants can be converted efficiently to class II-peptide complexes and, second, that most class II-associated peptides can still be generated in cells treated with inhibitors of cysteine proteases. Surprisingly, maturation of MHC class II in mice deficient in cathepsin D is unaffected, showing that this major aspartyl protease is not involved in degradation of Ii or in generation of the bulk of antigenic peptides.
引用
收藏
页码:549 / 560
页数:12
相关论文
共 78 条
[1]  
ADORINI L, 1993, J IMMUNOL, V151, P3576
[2]   INVARIANT CHAIN CLEAVAGE AND PEPTIDE LOADING IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II VESICLES [J].
AMIGORENA, S ;
WEBSTER, P ;
DRAKE, J ;
NEWCOMB, J ;
CRESSWELL, P ;
MELLMAN, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1729-1741
[3]   TRANSIENT ACCUMULATION OF NEW CLASS-II MHC MOLECULES IN A NOVEL ENDOCYTIC COMPARTMENT IN B-LYMPHOCYTES [J].
AMIGORENA, S ;
DRAKE, JR ;
WEBSTER, P ;
MELLMAN, I .
NATURE, 1994, 369 (6476) :113-120
[4]   IN-VIVO AND IN-VITRO FORMATION AND DISSOCIATION OF HLA-DR COMPLEXES WITH INVARIANT CHAIN-DERIVED PEPTIDES [J].
AVVA, RR ;
CRESSWELL, P .
IMMUNITY, 1994, 1 (09) :763-774
[5]   MHC CLASS-II-ASSOCIATED INVARIANT CHAIN CONTAINS A SORTING SIGNAL FOR ENDOSOMAL COMPARTMENTS [J].
BAKKE, O ;
DOBBERSTEIN, B .
CELL, 1990, 63 (04) :707-716
[6]   Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation [J].
Barois, N ;
Forquet, F ;
Davoust, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3641-3647
[7]   MAPPING FUNCTIONAL REGIONS IN THE LUMENAL DOMAIN OF THE CLASS II-ASSOCIATED INVARIANT CHAIN [J].
BIJLMAKERS, MJE ;
BENAROCH, P ;
PLOEGH, HL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :623-629
[8]   ALLELIC DIFFERENCES AFFECTING INVARIANT CHAIN DEPENDENCY OF MHC CLASS-II SUBUNIT ASSEMBLY [J].
BIKOFF, EK ;
GERMAIN, RN ;
ROBERTSON, EJ .
IMMUNITY, 1995, 2 (03) :301-310
[9]   ROLE FOR INTRACELLULAR PROTEASES IN THE PROCESSING AND TRANSPORT OF CLASS-II HLA ANTIGENS [J].
BLUM, JS ;
CRESSWELL, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (11) :3975-3979
[10]   Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes [J].
Brachet, V ;
Raposo, G ;
Amigorena, S ;
Mellman, I .
JOURNAL OF CELL BIOLOGY, 1997, 137 (01) :51-65